- Coordinator
- Uniwersytet Warminsko Mazurski W Olsztynie, Poland
- Runs
- 1 January 2027 to 31 December 2030
- Status
- Running
- EU funding
- €1.7m
- Total cost
- —
- Partners
- 21 organisations in 12 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101344557
What the project is doing
In the project's own words, from its summary on CORDIS.
SAFE-DADA proposes a comprehensive strategy for identifying falsified and substandard medicines by leveraging Nuclear Magnetic Resonance (NMR) relaxation and Nuclear Quadrupole Resonance (NQR) techniques. This approach transcends conventional methodsthat focus primarily on the composition and structure of pharmaceutical products, aiming instead at the innovative concept to characterize molecular dynamics and detect even subtle variations in molecular arrangement and interactions.
In parallel, the projectseeks to reveal and exploit synergies among a broad spectrum of complementary analytical techniques, including Chromatography, Mass Spectrometry, Photochemistry, Vibrational spectroscopy, Broadband Acoustic Resonance Dissolution Spectroscopy, and IsotopeRatio Mass Spectrometry, to integrate their strengths against the increasingly sophisticated routes of drug falsification. The ultimate concept rests on two complementary pillars, NMR-based and non-NMR methods, together to develop fast, reliable, and portablestrategies for drug authentication.
These objectives bring together experts from academia and industry, encompassing multidisciplinary expertise in physics, chemistry, pharmacology, life sciences, and engineering. The concerted effort spans not only a diverse range of molecular science approaches but also a broad array of pharmaceutical products, including antibiotics, oncological, antimicrobial, and antimalarial drugs, as well as antihistamines, antitussives, and herbal medicines.
The project also emphasizes knowledge exchange, offering extensive training for early-career researchers, not only to become experts in pharmaceutical analysis and drug authentication, but also to develop the unique ability to integrate and exploit synergies among diverse molecular science methods for a wide range of applications. Furthermore, SAFE-DADA raises public awareness, highlighting the scale and dangers of drug falsification.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Uniwersytet Warminsko Mazurski W Olsztynie | Olsztyn | Poland | Coordinator |
| Universidade Federal Do Rio De Janeiro | Rio De Janeiro | Brazil | Associatedpartner |
| Colegio Mayor De Nuestra Senora Delrosario Corporacion Sin Animo De Lucro | Bogota Dc | CO | Associatedpartner |
| Productos Roche SA | Bogota | CO | Associatedpartner |
| Martin-Luther-Universitat Halle-Wittenberg | Halle | Germany | Participant |
| Resonance Systems GmbH | Kirchheim Unter Teck | Germany | Participant |
| University College Cork - National University of Ireland, Cork | Cork | Ireland | Participant |
| Stelar SRL | Mede | Italy | Participant |
| Universita Degli Studi Del Piemonte Orientale Amedeo Avogadro | Vercelli | Italy | Participant |
| Universita Degli Studi Di Pavia | Pavia | Italy | Participant |
| Jomo Kenyatta University of Agriculture and Technology | Nairobi | Kenya | Associatedpartner |
| University of Nairobi | Nairobi | Kenya | Associatedpartner |
| Viva Healthcare Limited | Nairobi | Kenya | Associatedpartner |
| Universiti Kebangsaan Malaysia | Selangor Darul Ehsan | MY | Associatedpartner |
| National University of Sciences Andtechnology at Islamabad | Islamabad | PK | Associatedpartner |
| Seraph Pharmaceutical | Islamabad | PK | Associatedpartner |
| Uniwersytet Im. Adama Mickiewicza Wpoznaniu | Poznan | Poland | Participant |
| Institutul National De Cercetare-Dezvoltare Pentru Tehnologii Izotopice Si Moleculare-Incdtim Cluj-Napoca | Cluj - Napoca | Romania | Participant |
| Middle East Technical University | Ankara | Türkiye | Participant |
| Wellnessbiotics Saglikli Yasam Ve Modern Dogal Gida Takviyeleri Uretim Ve Ticaret Anonim Sirketi | Aksaray | Türkiye | Participant |
| Muhimbili University of Health and Allied Sciences | Dar Es Salaam | TZ | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI